Objective： To study the efficacy of modified Wuzhuyu Decoction Granule （加减吴茱萸汤颗粒剂, MWDG） in the treatment of migraine patients with cold and stasis obstructing meridian syndrome. Methods： This study was a...Objective： To study the efficacy of modified Wuzhuyu Decoction Granule （加减吴茱萸汤颗粒剂, MWDG） in the treatment of migraine patients with cold and stasis obstructing meridian syndrome. Methods： This study was a randomized, double-blind, placebo-controlled trial. A total of 78 migraine patients with cold and stasis obstructing meridian syndrome were recruited and randomly assigned by a ratio of 2：1 into a treatment group （51 cases） and a placebo group （27 cases）. Patients in the treatment group were treated with MWDG while placebo granules were applied in the control group. The treatment course lasted for 12 weeks with a follow-up of 4 weeks. The primary outcome measures included frequency and days of migraine attacks and the secondary outcome measures were analgesics consumption and visual analogue scale （VAS） scores. All outcome assessments were conducted respectively at baseline, the 4th, 8th and 12th week, and the end of follow-up. Results： In the treatment group, significant decrease in frequency of migraine attacks were observed since the 4th week and that of analgesics consumption since the 8th week （both P〈0.05）. While, in the placebo group, significant decrease in frequency of migraine attacks were observed since the 8th week and that of analgesics consumption since the 12th week （both P〈0.05）. No significant decrease in days of migraine attacks and VAS scores of migraine pain were observed in both groups. Between the two groups, there were significant differences in VAS scores and intensity of pain appeared in the 8th week （P〈0.05）. However, no significant differences were found in days and frequency of migraine attacks and analgesics consumption （P〉0.05）. Conclusions： MWDG was probably effective in the treatment of migraine especially for alleviating pain intensity. Furthermore, MWDG could reduce the frequency of migraine attacks and analgesics consumption sooner than the placebo.展开更多
目的:探究当归四逆加吴茱萸生姜汤调节雷诺病的系统药理学机制,筛选先导化合物。方法:基于中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology, TCMSP)和Cytoscape 3.6分析软件,构建当归四逆加吴茱萸...目的:探究当归四逆加吴茱萸生姜汤调节雷诺病的系统药理学机制,筛选先导化合物。方法:基于中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology, TCMSP)和Cytoscape 3.6分析软件,构建当归四逆加吴茱萸生姜汤的“中药-成分-靶点”调控网络,对本方调节靶点进行通路富集分析,综合使用系统药理学和计算机辅助药物设计的方法,筛选本方的潜在活性成分。结果:本方初步筛选出696个化合物成分,获得401个特异性靶点,形成“化合物-靶点”5 446调控对。本方调节靶点基因本体(gene ontology, GO)富集通路包括氨基酸结合、G蛋白偶联受体活性等生物学过程及线粒体基质、线粒体等细胞组分相关,受预激抑制、谷胱甘肽代谢过程、抑制性突触后电位等分子功能影响;京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes, KEGG)富集包括HIF-1信号通路、cAMP信号通路、IL-17信号通路等。分子对接和药效团筛选得出化合物(-)-Medicocarpin具有较好的潜在治疗作用。结论:当归四逆加吴茱萸生姜汤可能通过调节HIF-1信号通路、cAMP信号通路、IL-17信号通路等改善雷诺病;甘草中的(-)-Medicocarpi、Yinyanghuo D与吴茱萸中的Goshuyuamide II等可以作为治疗雷诺病的潜在有效成分。展开更多
基金Supported by the "Eleventh Five-Year Plan" of China State Science&Technology Ministry(No.2007BAI20B053)National Natural Science Foundation of China(No.81273688)
文摘Objective： To study the efficacy of modified Wuzhuyu Decoction Granule （加减吴茱萸汤颗粒剂, MWDG） in the treatment of migraine patients with cold and stasis obstructing meridian syndrome. Methods： This study was a randomized, double-blind, placebo-controlled trial. A total of 78 migraine patients with cold and stasis obstructing meridian syndrome were recruited and randomly assigned by a ratio of 2：1 into a treatment group （51 cases） and a placebo group （27 cases）. Patients in the treatment group were treated with MWDG while placebo granules were applied in the control group. The treatment course lasted for 12 weeks with a follow-up of 4 weeks. The primary outcome measures included frequency and days of migraine attacks and the secondary outcome measures were analgesics consumption and visual analogue scale （VAS） scores. All outcome assessments were conducted respectively at baseline, the 4th, 8th and 12th week, and the end of follow-up. Results： In the treatment group, significant decrease in frequency of migraine attacks were observed since the 4th week and that of analgesics consumption since the 8th week （both P〈0.05）. While, in the placebo group, significant decrease in frequency of migraine attacks were observed since the 8th week and that of analgesics consumption since the 12th week （both P〈0.05）. No significant decrease in days of migraine attacks and VAS scores of migraine pain were observed in both groups. Between the two groups, there were significant differences in VAS scores and intensity of pain appeared in the 8th week （P〈0.05）. However, no significant differences were found in days and frequency of migraine attacks and analgesics consumption （P〉0.05）. Conclusions： MWDG was probably effective in the treatment of migraine especially for alleviating pain intensity. Furthermore, MWDG could reduce the frequency of migraine attacks and analgesics consumption sooner than the placebo.
文摘目的:探究当归四逆加吴茱萸生姜汤调节雷诺病的系统药理学机制,筛选先导化合物。方法:基于中药系统药理学数据库与分析平台(traditional Chinese medicine systems pharmacology, TCMSP)和Cytoscape 3.6分析软件,构建当归四逆加吴茱萸生姜汤的“中药-成分-靶点”调控网络,对本方调节靶点进行通路富集分析,综合使用系统药理学和计算机辅助药物设计的方法,筛选本方的潜在活性成分。结果:本方初步筛选出696个化合物成分,获得401个特异性靶点,形成“化合物-靶点”5 446调控对。本方调节靶点基因本体(gene ontology, GO)富集通路包括氨基酸结合、G蛋白偶联受体活性等生物学过程及线粒体基质、线粒体等细胞组分相关,受预激抑制、谷胱甘肽代谢过程、抑制性突触后电位等分子功能影响;京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes, KEGG)富集包括HIF-1信号通路、cAMP信号通路、IL-17信号通路等。分子对接和药效团筛选得出化合物(-)-Medicocarpin具有较好的潜在治疗作用。结论:当归四逆加吴茱萸生姜汤可能通过调节HIF-1信号通路、cAMP信号通路、IL-17信号通路等改善雷诺病;甘草中的(-)-Medicocarpi、Yinyanghuo D与吴茱萸中的Goshuyuamide II等可以作为治疗雷诺病的潜在有效成分。
